Veliparib Completed Phase 3 Trials for Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT02264990Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers